Therapeutic area intelligence for Palliative Care with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

Phase →

Recent signals(2)

ClinicalJuly 30, 2026

Phase II/III Trial of Haloperidol and Lorazepam for Agitated Delirium in Advanced Cancer Patients

A phase II/III trial is evaluating the efficacy of haloperidol and lorazepam in managing persistent agitated delirium in advanced cancer patients receiving palliative care.

ClinicalJuly 26, 2026

Study on CHW Support to Enhance Palliative Care in Advanced Cancer Patients

A study is underway to evaluate the impact of community health worker support on palliative care outcomes for African American patients with advanced cancer.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.